상세 보기

A multicenter phase II neoadjuvant trial of bevacizumab combined with docetaxel plus carboplatin in the treatment of triple-negative breast cancer: Korean Cancer Study Group (KCSG-BR 0905, NCT 01208480).

Kim, Hye Ryun;
Jung, Kyung Hae;
Im, Seock-Ah;
Im, Young-Hyuck;
Kang, Seok Yun;
... Lee, Hye Yoon;
외 13명

제목: A multicenter phase II neoadjuvant trial of bevacizumab combined with docetaxel plus carboplatin in the treatment of triple-negative breast cancer: Korean Cancer Study Group (KCSG-BR 0905, NCT 01208480).

저자: Kim, Hye Ryun; Jung, Kyung Hae; Im, Seock-Ah; Im, Young-Hyuck; Kang, Seok Yun; Park, Kyong Hwa; Lee, Keun Seok; Lee, Soohyeon; Ahn, Jin-Hee; Kim, Sung-Bae; Lee, Kyung-Hun; Park, Yeon Hee; Ahn, Jin Seok; Kim, Ku Sang; Lee, Hye Yoon; Ro, Jungsil; Park, Byeong-Woo; Kim, Seung Il; Sohn, Joo Hyuk

DOI: 10.1200/jco.2012.30.15_suppl.2542

발행일: 2012-05-20

학회명: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

개최지: Chicago, IL

개최국가: 미국

학회 개최일: 2012-06-01 ~ 2012-06-06

언어: ENG